AI-generated summary
The authors studied whether red or near-infrared light (photobiomodulation) applied before photodynamic therapy could increase production of protoporphyrin IX, the light-sensitive compound used in cancer treatment. In cell experiments and in tumors grown on chicken embryo membranes, they report that combining the two approaches significantly enhanced the potency of photodynamic therapy. The work was conducted in vitro and in chicken embryo tumors, not in patients.
- Who or what was studied
- Cultured cells and tumors grown on the chicken embryo chorioallantoic membrane; no human participants are described in the abstract.
- Limits stated in the abstract
- The abstract describes only in vitro and chicken embryo tumor experiments, with no human data reported.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Photobiomodulation, Reactive oxygen species, Near-infrared, Mitochondria. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.